These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12176950)

  • 1. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial.
    Serruys PW; Degertekin M; Tanabe K; Abizaid A; Sousa JE; Colombo A; Guagliumi G; Wijns W; Lindeboom WK; Ligthart J; de Feyter PJ; Morice MC;
    Circulation; 2002 Aug; 106(7):798-803. PubMed ID: 12176950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistent inhibition of neointimal hyperplasia after sirolimus-eluting stent implantation: long-term (up to 2 years) clinical, angiographic, and intravascular ultrasound follow-up.
    Degertekin M; Serruys PW; Foley DP; Tanabe K; Regar E; Vos J; Smits PC; van der Giessen WJ; van den Brand M; de Feyter P; Popma JJ
    Circulation; 2002 Sep; 106(13):1610-3. PubMed ID: 12270850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of coronary remodeling after sirolimus-eluting stent implantation by serial three-dimensional intravascular ultrasound.
    Degertekin M; Regar E; Tanabe K; Lemos P; Lee CH; Smits P; de Feyter P; Bruining N; Sousa E; Abizaid A; Ligthart J; Serruys PW
    Am J Cardiol; 2003 May; 91(9):1046-50. PubMed ID: 12714144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed intravascular ultrasound analysis of Zotarolimus-eluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial).
    Sakurai R; Hongo Y; Yamasaki M; Honda Y; Bonneau HN; Yock PG; Cutlip D; Popma JJ; Zimetbaum P; Fajadet J; Kuntz RE; Wijns W; Fitzgerald PJ;
    Am J Cardiol; 2007 Sep; 100(5):818-23. PubMed ID: 17719326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: intravascular ultrasound results from ENDEAVOR III.
    Miyazawa A; Ako J; Hongo Y; Hur SH; Tsujino I; Courtney BK; Hassan AH; Kandzari DE; Honda Y; Fitzgerald PJ;
    Am Heart J; 2008 Jan; 155(1):108-13. PubMed ID: 18082499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravascular ultrasound results from the ENDEAVOR IV trial: randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease.
    Waseda K; Miyazawa A; Ako J; Hasegawa T; Tsujino I; Sakurai R; Yock PG; Honda Y; Kandzari DE; Leon MB; Fitzgerald PJ;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):779-84. PubMed ID: 19695548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirolimus-eluting stent implantation in small coronary arteries: a three dimensional intravascular ultrasound study from the SIRIUS trial.
    Kaneda H; Ako J; Terashima M; Morino Y; Honda Y; Yock PG; Leon MB; Moses JW; Fitzgerald PJ;
    Int J Cardiol; 2010 Jan; 138(2):126-30. PubMed ID: 18804877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL): sirolimus-eluting stents inhibit restenosis irrespective of the vessel size.
    Regar E; Serruys PW; Bode C; Holubarsch C; Guermonprez JL; Wijns W; Bartorelli A; Constantini C; Degertekin M; Tanabe K; Disco C; Wuelfert E; Morice MC;
    Circulation; 2002 Oct; 106(15):1949-56. PubMed ID: 12370218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial.
    Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Costa MA; Alfonso F; Gómez-Hospital JA; Hernández-Antolín R; Bañuelos C; Goicolea J; Fernández-Avilés F; Bass T; Escaned J; Moreno R; Fernández C; Macaya C;
    J Am Coll Cardiol; 2006 Jun; 47(11):2172-9. PubMed ID: 16750681
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of four-year coronary artery response after sirolimus-eluting stent implantation using serial quantitative intravascular ultrasound and computer-assisted grayscale value analysis for plaque composition in event-free patients.
    Aoki J; Abizaid AC; Serruys PW; Ong AT; Boersma E; Sousa JE; Bruining N
    J Am Coll Cardiol; 2005 Nov; 46(9):1670-6. PubMed ID: 16256867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained suppression of neointimal proliferation by sirolimus-eluting stents: one-year angiographic and intravascular ultrasound follow-up.
    Sousa JE; Costa MA; Abizaid AC; Rensing BJ; Abizaid AS; Tanajura LF; Kozuma K; Van Langenhove G; Sousa AG; Falotico R; Jaeger J; Popma JJ; Serruys PW
    Circulation; 2001 Oct; 104(17):2007-11. PubMed ID: 11673337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial.
    van Hout BA; Serruys PW; Lemos PA; van den Brand MJ; van Es GA; Lindeboom WK; Morice MC
    Heart; 2005 Apr; 91(4):507-12. PubMed ID: 15772214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-in-human evaluation of a bioabsorbable polymer-coated sirolimus-eluting stent: imaging and clinical results of the DESSOLVE I Trial (DES with sirolimus and a bioabsorbable polymer for the treatment of patients with de novo lesion in the native coronary arteries).
    Ormiston J; Webster M; Stewart J; Vrolix M; Whitbourn R; Donohoe D; Knape C; Lansky A; Attizzani GF; Fitzgerald P; Kandzari DE; Wijns W
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1026-34. PubMed ID: 24055443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-year intravascular ultrasound observations in diabetic patients treated with single and double dose sirolimus-eluting stents: results of the double dose diabetes (3D) study.
    Hur SH; Ako J; Shimada Y; Tsujino I; Hassan AH; Abizaid A; Shiran A; Lewis BS; Guagliumi G; Cohen SA; Honda Y; Fitzgerald PJ; Sousa JE
    J Invasive Cardiol; 2008 Aug; 20(8):411-6. PubMed ID: 18688066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
    Antonsen L; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Kaltoft A; Hansen HS; Thuesen L; Lassen JF; Jensen LO
    Catheter Cardiovasc Interv; 2014 May; 83(6):864-72. PubMed ID: 23996918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravascular ultrasound comparison of sirolimus-eluting stent versus bare metal stent implantation in diseased saphenous vein grafts (from the RRISC [Reduction of Restenosis In Saphenous Vein Grafts With Cypher Sirolimus-Eluting Stent] trial).
    Agostoni P; Vermeersch P; Semeraro O; Verheye S; Van Langenhove G; Van den Heuvel P; Convens C; Van den Branden F; Bruining N
    Am J Cardiol; 2007 Jul; 100(1):52-8. PubMed ID: 17599440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial.
    Jensen LO; Maeng M; Thayssen P; Villadsen A; Krusell L; Botker HE; Pedersen KE; Aaroe J; Christiansen EH; Vesterlund T; Hansen KN; Ravkilde J; Tilsted HH; Lassen JF; Thuesen L
    EuroIntervention; 2011 Jul; 7(3):323-31. PubMed ID: 21729834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of sirolimus-eluting stents on outcome in diabetic patients: a SIRIUS (SIRolImUS-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo coronary artery lesions) substudy.
    Moussa I; Leon MB; Baim DS; O'Neill WW; Popma JJ; Buchbinder M; Midwall J; Simonton CA; Keim E; Wang P; Kuntz RE; Moses JW
    Circulation; 2004 May; 109(19):2273-8. PubMed ID: 15123524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of zotarolimus-eluting stents with sirolimus-eluting and paclitaxel-eluting stents: intimal hyperplasia and vascular changes assessed by volumetric intravascular ultrasound analysis.
    Kang SJ; Mintz GS; Park DW; Lee SW; Kim YH; Lee CW; Han KH; Kim JJ; Park SW; Park SJ
    Circ Cardiovasc Interv; 2011 Apr; 4(2):139-45. PubMed ID: 21364151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Head-to-head comparison between sirolimus-eluting and paclitaxel-eluting stents in patients with complex coronary artery disease: an intravascular ultrasound study".
    Cervinka P; Costa MA; Angiolillo DJ; Spacek R; Bystron M; Kvasnák M; Veselka J; Nanda H; Futamatsu H; Futamatsu K
    Catheter Cardiovasc Interv; 2006 Jun; 67(6):846-51. PubMed ID: 16683273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.